tetano
Editor, Senior Moderator
Vaccine major Serum Institute has commenced a campaign to bring down the number of H1N1 fatal cases in the country. The fatal cases are estimated at 989 out of the 12,401 cases reported in the country between June 2010 and September 26, 2010. In fact, in Karnataka alone 79 deaths were reported in the last 90 days.
The company is now creating a mass awareness drive to help bring down the cases and control the deaths. Karnataka has reported to be the second highest in H1N1 deaths after Maharashtra accounting for 248 deaths from the 4,295 cases. Of the 248 deaths 79 fatal cases came in between June and September 2010.
The National Institute of Virology has confirmed the second wave of the dreaded influenza. The H1N1 activity declined in April and May, but showed a a swift increase from June. The most common cause of death in Swine Flu is respiratory failure. Other causes of death are pneumonia leading to sepsis, high fever resulting in neurological disorders, dehydration, electrolyte imbalance and kidney failure.
?This is alarming and we need to contain the spread through a mass campaign,? Dr Prajakt J Barde, assistant medical director, Serum Institute India told Pharmabiz.
..
http://www.pharmabiz.com/article/detnews.asp?articleid=57762§ionid=
The company is now creating a mass awareness drive to help bring down the cases and control the deaths. Karnataka has reported to be the second highest in H1N1 deaths after Maharashtra accounting for 248 deaths from the 4,295 cases. Of the 248 deaths 79 fatal cases came in between June and September 2010.
The National Institute of Virology has confirmed the second wave of the dreaded influenza. The H1N1 activity declined in April and May, but showed a a swift increase from June. The most common cause of death in Swine Flu is respiratory failure. Other causes of death are pneumonia leading to sepsis, high fever resulting in neurological disorders, dehydration, electrolyte imbalance and kidney failure.
?This is alarming and we need to contain the spread through a mass campaign,? Dr Prajakt J Barde, assistant medical director, Serum Institute India told Pharmabiz.
..
http://www.pharmabiz.com/article/detnews.asp?articleid=57762§ionid=